Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03624569 · ClinicalTrials.gov registry record · NA

Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome

A NA study of Cardiovascular Diseases and Endothelial Dysfunction, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT03624569 is a NA study of Cardiovascular Diseases and Endothelial Dysfunction that has completed, run by Ohio State University. The registered enrollment target is 32 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03624569, a NA study of Cardiovascular Diseases and Endothelial Dysfunction, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study is focused on assessing potential health benefits of daily consumption of potatoes, specifically its resistant starch content (i.e. nondigestible carbohydrate), on blood vessel and gut health function in adults with metabolic syndrome. It is expected that the daily consumption of potatoes for two weeks, within a diet that follows the Dietary Guidelines for Americans, will improve blood vessel function in association with decreasing gut permeability ("leaky gut") that results in the absorption of bacterial toxins that reside in the intestine. Outcomes will therefore support dietary recommendations for potatoes to support vascular and gastrointestinal health.

Interventions

  • OTHER Bagel
  • OTHER Potato

Study Locations (1)

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2018-08-15
Est. Completion 2020-07-16
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT03624569

The ClinicalTrials.gov registry entry for NCT03624569 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Bagel is the first listed.

NCT03624569 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03624569 about?

NCT03624569 is a clinical study titled "Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome". This study is focused on assessing potential health benefits of daily consumption of potatoes, specifically its resistant starch content (i.e. nondigestible carbohydrate), on blood vessel and gut health function in adults with metabolic syndrome. It is expected that the daily consumption of potatoes...

What is the current status of trial NCT03624569?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-08-15. Estimated completion is 2020-07-16.

What conditions does trial NCT03624569 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Endothelial Dysfunction, Gut Health, Endotoxemia, Postprandial Hyperglycemia.

What interventions are being tested in trial NCT03624569?

The interventions under investigation include: Bagel (OTHER), Potato (OTHER).

Who is sponsoring clinical trial NCT03624569?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03624569 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.